Description
Uses of Medicine:
Everolimus is a kinase inhibitor. Patients, Healthcare Professionals (HCPs), or Hospitals can buy Everolimus 2.5 mg/5 mg/7.5 mg/10 mg Tablets online from India through THE INDIAN PHARMA (a trusted Everolimus Supplier, Exporter, and Contract Manufacturer in India).Everolimus is prescribed for the treatment of several advanced cancers and tumors in adults. It works by blocking specific proteins that promote cancer cell growth, helping to slow down disease progression. It is used for the management and treatment of:
Advanced Breast Cancer- Everolimus is used along with the medicine exemestane to treat postmenopausal women with hormone receptor-positive (HR+), and HER2-negative breast cancer.
- It is prescribed after failure of prior treatments with letrozole or anastrozole.
- Everolimus is used for adults with progressive neuroendocrine tumors of pancreatic origin (PNET).
- It is also used for well-differentiated, non-functional NETs of the gastrointestinal (GI) or lung origin that are unresectable, locally advanced, or metastatic.
- Limitations: It is not indicated for treating patients with functional carcinoid tumors.
- It is prescribed for adults with advanced RCC who have experienced treatment failure with sunitinib or sorafenib.
- Everolimus is used in adults with renal angiomyolipoma and TSC when the condition does not require immediate surgery.
Dosage & Side Effects:
Dosage for Hormone Receptor-Positive, HER2-Negative Breast Cancer:
The recommended dosage of Everolimus is 10 mg orally once daily until disease progression or unacceptable toxicity.Dosage for Neuroendocrine Tumors (NET):
The recommended dosage of Everolimus is 10 mg orally once daily until there is evidence of disease progression or unacceptable toxicity.Dosage for Renal Cell Carcinoma (RCC):
The recommended dosage of Everolimus is 10 mg orally once daily until there is evidence of disease progression or unacceptable toxicity.Dosage for Tuberous Sclerosis Complex (TSC)-Associated Renal Angiomyolipoma:
The recommended dosage of Everolimus is 10 mg orally once daily until there is evidence of disease progression or unacceptable toxicity.Dosage for Tuberous Sclerosis Complex (TSC)-Associated Subependymal Giant Cell Astrocytoma (SEGA):
The recommended starting dosage of Everolimus is 4.5 mg/m2 orally once daily until there is evidence of disease progression or unacceptable toxicity.Dosage for Tuberous Sclerosis Complex (TSC)-Associated Partial-Onset Seizures:
The recommended starting dosage of EverolimusZ is 5 mg/m2 orally once daily until there is evidence of disease progression or unacceptable toxicity.The most common side effects of Everolimus tablets are mouth sores, infections, diarrhea, cough, skin rash, fatigue, nausea, headache, decreased appetite, weight loss, and high blood sugar levels.